Form 8-K PTC THERAPEUTICS, INC. For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
PTC Therapeutics (PTCT) Tops Q2 EPS by 13c; Offers FY16 Outlook
August 4, 2016 5:10 PM EDTPTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($1.14), $0.13 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.68 million.
2016 Guidance:
Total ex-U.S. Translarna nmDMD revenues for 2016 are anticipated to... More
